Core Scientific's Upcoming Earnings: A Critical Test for the High-Flying Stock
25.02.2026 - 10:23:30 | boerse-global.deAll eyes are on Core Scientific as it prepares to release its fourth-quarter and full-year 2025 financial results after the U.S. market closes on Monday, March 2. The report arrives at a pivotal moment for the company, whose shares have surged more than 80% over the past year. The upcoming figures will provide crucial insight into whether this remarkable momentum is supported by fundamental business performance and progress in its digital infrastructure operations.
Strategic Shifts and Boardroom Changes
The earnings release follows closely on the heels of a significant corporate governance update. Core Scientific's management has reached a cooperation agreement with activist investor Two Seas Capital. As part of this strategic realignment, the company's board will be expanded by three independent members and capped at nine seats by 2027. Furthermore, Chairman Jordan Levy will not stand for re-election at this year's annual shareholder meeting.
Market Expectations and Recent Trading
Market experts are forecasting quarterly revenue of $118.44 million. On the profitability front, analysts anticipate a per-share loss ranging between $0.18 and $0.27. The equity closed Thursday's session at $17.87, marking a daily gain of 5.8%. With a market capitalization of approximately $5.5 billion, the stock currently trades well above its 52-week low of $6.20.
Institutional Positioning and Derivative Sentiment
Institutional investors have made substantial adjustments to their holdings ahead of the annual report. Pentwater Capital increased its position by 22 million shares, while financial giant UBS acquired 13 million shares. Oaktree Capital also expanded its stake by nearly two million shares. Separately, the state of Wyoming reported a new position valued at $66,000.
Should investors sell immediately? Or is it worth buying Core Scientific?
Concurrently, activity in the options market has intensified notably. In recent trading, call options accounted for almost 88% of the total volume. Contracts with a strike price of $18.50 were particularly sought after, signaling a bullish outlook among market participants.
The detailed financial statements will be published following the close of trading in New York on Monday. Management will host a conference call to discuss the results at 10:30 p.m. Central European Time.
Ad
Core Scientific Stock: New Analysis - 25 February
Fresh Core Scientific information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt kostenlos anmelden
Jetzt abonnieren.


